Related Experiment Video
Updated: Jul 4, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Toll-like receptor signaling in the ischemic heart
Stefan Frantz1, Georg Ertl, Johann Bauersachs
1Medizinische Klinik und Poliklinik I, Herzkreislauf-Zentrum, Universitätsklinikum Würzburg, Würzburg, Germany. frantz_s@medizin.uni-wuerzburg.de
Abstract:
Toll-like receptors (TLRs) have been identified as primary innate immune receptors. They distinguish among different patterns of pathogens and rapidly activate an innate immune response. However, TLRs can also be stimulated by host-derived molecules. TLRs are expressed in the cardiovascular system and could thus be a key link between cardiovascular diseases and the immune system. Increasing evidence suggests that TLR signaling promotes injury in the heart after ischemia, ischemia/reperfusion or hypertrophic stimuli. Herein we review the experimental and clinical evidence for the involvement of TLR and its downstream signaling molecules in cardiac ischemic injury.
Related Concept Videos
Amplifying Signals via Second Messengers
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Signal Transduction: Overview
Typically, signal transduction involves three...
Paracrine Signaling
Nitric Oxide Signaling Pathway